SPECTRUM PHARMACEUTICALS INC Litigation

Oct 16, 2026

Motion for Final Approval of Settlement

The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.

Jun 22, 2026

Preliminary Approval of Settlement

The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.

Jun 22, 2026

Notice of Pendency

Jun 22, 2026

Proof of Claim Form

To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.

Jun 1, 2026

Motion for Preliminary Approval of Settlement

The parties have asked the court to give preliminary approval to a proposed settlement. The judge will review the request and decide whether the settlement can move forward to the next stage. If approved, potential class members will generally receive information about the settlement and their rights, including any deadlines for taking action.

Oct 30, 2024

Motion for Class Certification

The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.

Jan 23, 2024

Motion to Dismiss Denied in Part

The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.

Jul 25, 2023

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

May 30, 2023

First Amended Complaint

A new complaint has been filed on behalf of certain investors in SPECTRUM PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

May 26, 2023

First Amended Complaint

A new complaint has been filed on behalf of certain investors in SPECTRUM PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Mar 21, 2023

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jan 30, 2023

Additional Complaint (Change in CP)

Dec 19, 2022

Additional Complaint

Another plaintiff has filed a complaint on behalf of investors in SPECTRUM PHARMACEUTICALS INC. The allegations and class definitions are substantively the same.

Dec 5, 2022

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in SPECTRUM PHARMACEUTICALS INC.